Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DCL000210

Drug Information
NameR763
CompanyMerck-Serono Lab
IndicationHaematological Malignancies
[ICD9: 200-209   ICD10: C81-C96]
Phase I    
Therapeutic ClassAntineoplastic Agents
ClinicalTrials.govNCT01080664;
TargetAurora-AInhibitor[1]
Aurora-AMultitarget[1]
Aurora-BInhibitor[1]
Aurora-BMultitarget[1]
Ref 1J Cancer Res Clin Oncol. 2010 Jan;136(1):99-113.Preclinical characterization of Aurora kinase inhibitor R763/AS703569 identified through an image-based phenotypic screen. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543